Literature DB >> 1336435

Alpha-tocopherol, lipids and lipoproteins in knee-joint synovial fluid and serum from patients with inflammatory joint disease.

K Fairburn1, M Grootveld, R J Ward, C Abiuka, M Kus, R B Williams, P G Winyard, D R Blake.   

Abstract

1. We have determined the antioxidant status of synovial fluid and serum of patients with inflammatory joint disease in terms of the biologically active lipid-soluble antioxidant, alpha-tocopherol. Synovial fluid concentrations of alpha-tocopherol were significantly lower relative to those of paired serum samples (P < 0.001). Serum levels of alpha-tocopherol in these patients did not differ significantly from those in control serum. 2. Lower concentrations of cholesterol, triacylglycerol and low-density lipoprotein were also observed in patients' synovial fluid compared with matched serum samples. However, multiple regression analysis of the data indicated that there remained a significant depletion of alpha-tocopherol, which was largely independent of these co-variables, in inflammatory synovial fluid. These findings are consistent with the consumption of alpha-tocopherol within the inflamed joint via its role in terminating the process of lipid peroxidation. 3. Nuclear magnetic resonance spectroscopic analysis of matched inflammatory synovial fluid and serum confirmed lower concentrations of triacylglycerol in synovial fluid together with evidence of a shortened mean triacylglycerol chain length. The latter metabolic difference suggests an increased utilization of triacylglycerols for energy within the inflamed joint.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1336435     DOI: 10.1042/cs0830657

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  14 in total

Review 1.  Influence of hypoxia in inflammatory synovitis.

Authors:  T Bodamyali; C R Stevens; M E Billingham; S Ohta; D R Blake
Journal:  Ann Rheum Dis       Date:  1998-12       Impact factor: 19.103

2.  Putative analgesic activity of repeated oral doses of vitamin E in the treatment of rheumatoid arthritis. Results of a prospective placebo controlled double blind trial.

Authors:  S E Edmonds; P G Winyard; R Guo; B Kidd; P Merry; A Langrish-Smith; C Hansen; S Ramm; D R Blake
Journal:  Ann Rheum Dis       Date:  1997-11       Impact factor: 19.103

3.  2nd International meeting on synovium cell biology, physiology and pathology. Canterbury, United Kingdom, 21-23 September 1994. Proceedings and abstracts.

Authors: 
Journal:  Ann Rheum Dis       Date:  1995-06       Impact factor: 19.103

Review 4.  Oxygen radicals, nitric oxide and human inflammatory joint disease.

Authors:  B Halliwell
Journal:  Ann Rheum Dis       Date:  1995-06       Impact factor: 19.103

5.  [Selenium concentration in erythrocytes of patients with rheumatoid arthritis. Clinical and laboratory chemistry infection markers during administration of selenium].

Authors:  K Heinle; A Adam; M Gradl; M Wiseman; O Adam
Journal:  Med Klin (Munich)       Date:  1997-09-15

6.  Alpha-linolenic acid in the treatment of rheumatoid arthritis. A double-blind, placebo-controlled and randomized study: flaxseed vs. safflower seed.

Authors:  D C Nordström; V E Honkanen; Y Nasu; E Antila; C Friman; Y T Konttinen
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

Review 7.  [Diet in rheumatic disease].

Authors:  O Adam; S Fasse; O Ditrich
Journal:  Z Rheumatol       Date:  2009-09       Impact factor: 1.372

8.  Use of methyl prednisolone and antioxidants in mercuric chloride-induced experimental vasculitis.

Authors:  F J Qasim; P W Mathieson; S Thiru; D B Oliveira
Journal:  Clin Exp Immunol       Date:  1994-10       Impact factor: 4.330

9.  Oxidative stress and calcium-phosphorus levels in Rheumatoid arthritis.

Authors:  S D Walwadkar; A N Suryakar; R V Katkam; K M Kumbar; R D Ankush
Journal:  Indian J Clin Biochem       Date:  2006-09

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.